PolyC-RNA-binding protein 1 (PCBP1) enhances tropomyosin 3 (TPM3) mRNA stability to promote the progression of esophageal squamous cell carcinoma

References

• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021 May;71(3):209–249.
   PubMed Web of Science ®Google Scholar
• Lin DC, Hao JJ, Nagata Y, et al. Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat Genet. 2014 May;46(5):467–473.
   PubMed Web of Science ®Google Scholar
• Reichenbach ZW, Murray MG, Saxena R, et al. Clinical and translational advances in esophageal squamous cell carcinoma. Adv Cancer Res. 2019;144:95–135.
   PubMed Web of Science ®Google Scholar
• Thrift AP. Global burden and epidemiology of Barrett oesophagus and oesophageal cancer. Nat Clin Pract Gastroenterol Hepatol. 2021 Jun;18(6):432–443.
   Google Scholar
• Song Q, Wang X, Yu IT, et al. Processed food consumption and risk of esophageal squamous cell carcinoma: a case-control study in a high risk area. Cancer Sci. 2012 Nov;103(11):2007–2011.
   PubMed Web of Science ®Google Scholar
• Zhao L, Li YC, Wu JP, et al. Increased risk of esophageal squamous cell carcinoma associated with frequent and long-term consumption of salted meat and salted fat. J Int Med Res. 2019 Aug;47(8):3841–3849.
   PubMed Web of Science ®Google Scholar
• Shi F, Yan F, Jin M, et al. Pre-diagnosis consumption of preserved vegetables and prognosis of invasive oesophageal squamous cell carcinoma: a prospective cohort study in one high-risk area in China. J Int Med Res. 2018 Oct;46(10):4306–4314.
   PubMed Web of Science ®Google Scholar
• Yu C, Tang H, Guo Y, et al. Hot tea consumption and its interactions with alcohol and tobacco use on the risk for esophageal cancer: a population-based cohort study. Ann Intern Med. 2018 Apr 3;168(7):489–497.
   PubMed Web of Science ®Google Scholar
• Qi YJ, Jiao YL, Chen P, et al. Porphyromonas gingivalis promotes progression of esophageal squamous cell cancer via TGFβ-dependent Smad/YAP/TAZ signaling. PLoS Biol. 2020 Sep;18(9):e3000825.
   PubMed Web of Science ®Google Scholar
• Liang G, Wang H, Shi H, et al. Porphyromonas gingivalis promotes the proliferation and migration of esophageal squamous cell carcinoma through the miR-194/GRHL3/PTEN/Akt axis. ACS Infect Dis. 2020 May 8;6(5):871–881.
   PubMed Web of Science ®Google Scholar
• Xie FJ, Zhang YP, Zheng QQ, et al. Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis. World J Gastroenterol. 2013 Sep 28;19(36):6098–6107.
   PubMed Web of Science ®Google Scholar
• Al-Haddad S, El-Zimaity H, Hafezi-Bakhtiari S, et al. Infection and esophageal cancer. Ann N Y Acad Sci. 2014 Sep;1325(1):187–196.
   PubMedGoogle Scholar
• Gao YB, Chen ZL, Li JG, et al. Genetic landscape of esophageal squamous cell carcinoma. Nat Genet. 2014 Oct;46(10):1097–1102.
   PubMed Web of Science ®Google Scholar
• Lee KTW, Smith RA, Gopalan V, et al. Targeted single gene mutation in esophageal adenocarcinoma. Methods Mol Biol. 2018;1756:213–229.
   PubMedGoogle Scholar
• Hitchcock-degregori SE. Tropomyosin: function follows structure. Adv Exp Med Biol. 2008;644:60–72.
   PubMed Web of Science ®Google Scholar
• Lees JG, Bach CT, O’Neill GM. Interior decoration: tropomyosin in actin dynamics and cell migration. Cell Adh Migr. 2011 Mar-Apr;5(2):181–186.
   PubMed Web of Science ®Google Scholar
• Lin W, Lin J, Chen B, et al. Tropomyosin3 is associated with invasion, migration, and prognosis in esophageal squamous cell carcinoma. 2016;9 :11313–11323.
   Google Scholar
• Li Q, Dai Z, Xia C, et al. Suppression of long non-coding RNA MALAT1 inhibits survival and metastasis of esophagus cancer cells by sponging miR-1-3p/CORO1C/TPM3 axis. Mol Cell Biochem. 2020 Jul;470(1–2):165–174.
   PubMed Web of Science ®Google Scholar
• Yu SB, Gao Q, Lin WW, et al. Proteomic analysis indicates the importance of TPM3 in esophageal squamous cell carcinoma invasion and metastasis. Mol Med Rep. 2017 Mar;15(3):1236–1242.
   PubMed Web of Science ®Google Scholar
• Chen S, Shen Z, Gao L, et al. TPM3 mediates epithelial-mesenchymal transition in esophageal cancer via MMP2/MMP9. Ann Transl Med. 2021 Aug;9(16):1338.
   PubMed Web of Science ®Google Scholar
• Pereira B, Billaud M, Almeida R. RNA-binding proteins in cancer: old players and new actors. Trends Cancer. 2017 Jul;3(7):506–528.
   PubMed Web of Science ®Google Scholar
• Su X, Feng X, Gao C, et al. ROR promotes the proliferation and migration of esophageal cancer through regulating miR-145/LMNB2 signal axis. Am J Transl Res. 2020;12(11):7223–7235.
   PubMed Web of Science ®Google Scholar
• Liang X, Zhang Z, Wang L, et al. Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer. Bioengineered. 2021 Dec;12(2):10023–10036.
   PubMed Web of Science ®Google Scholar
• Lu W, Zhou M, Wang B, et al. Roquin1 inhibits the proliferation of breast cancer cells by inducing G1/S cell cycle arrest via selectively destabilizing the mRNAs of cell cycle-promoting genes. J Exp Clin Cancer Res. 2020 Nov 23;39(1):255.
   PubMed Web of Science ®Google Scholar
• Hentze MW, Castello A, Schwarzl T, et al. A brave new world of RNA-binding proteins. Nat Rev Mol Cell Biol. 2018 May;19(5):327–341.
   PubMed Web of Science ®Google Scholar
• Corley M, Burns MC, Yeo GW. How RNA-binding proteins interact with RNA: molecules and mechanisms. Mol Cell. 2020 Apr 2;78(1):9–29.
   PubMed Web of Science ®Google Scholar
• Amatu A, Sartore-Bianchi A, Bencardino K, et al. Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer. Ann Oncol. 2019 Nov 1;30(Suppl_8):viii5–viii15.
   PubMedGoogle Scholar
• Chen Q, Gu M, Cai ZK, et al. TGF-β1 promotes epithelial-to-mesenchymal transition and stemness of prostate cancer cells by inducing PCBP1 degradation and alternative splicing of CD44. Cell Mol Life Sci. 2021 Feb;78(3):949–962.
   PubMed Web of Science ®Google Scholar
• Shi H, Li H, Yuan R, et al. PCBP1 depletion promotes tumorigenesis through attenuation of p27(Kip1) mRNA stability and translation. J Exp Clin Cancer Res. 2018 Aug 7;37(1):187.
   PubMedGoogle Scholar
• Zhang Y, Meng L, Xiao L, et al. The RNA-binding protein PCBP1 functions as a tumor suppressor in prostate cancer by inhibiting mitogen activated protein kinase 1. Cell Physiol Biochem. 2018;48(4):1747–1754.
   PubMedGoogle Scholar
• Wang H, Vardy LA, Tan CP, et al. PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase. Cancer Cell. 2010 Jul 13;18(1):52–62.
   PubMed Web of Science ®Google Scholar
• Gerstberger S, Hafner M, Tuschl T. A census of human RNA-binding proteins. Nat Rev Genet. 2014 Dec;15(12):829–845.
   PubMed Web of Science ®Google Scholar
• Dukovski D, Villella A, Bastos C, et al. Amplifiers co-translationally enhance CFTR biosynthesis via PCBP1-mediated regulation of CFTR mRNA. J Cystic Fibrosis. 2020 Sep;19(5):733–741.
   PubMed Web of Science ®Google Scholar
• Zhou S, Ma X, Wang ZJ, et al. Research on the establishment of a TPM3 monoclonal stable transfected PANC-1 cell line and the experiment of the EMT occurrence in human pancreatic cancer. Onco Targets Ther. 2019;12:5577–5587.
   PubMed Web of Science ®Google Scholar
• Huang S, Luo K, Jiang L, et al. PCBP1 regulates the transcription and alternative splicing of metastasis‑related genes and pathways in hepatocellular carcinoma. Sci Rep. 2021 Dec 2;11(1):23356.
   PubMed Web of Science ®Google Scholar
• Zhao L, Wang ZG, Zhang P, et al. Poly r(C) binding protein 1 regulates posttranscriptional expression of the ubiquitin ligase TRIM56 in ovarian cancer. IUBMB Life. 2019 Feb;71(2):177–182.
   PubMed Web of Science ®Google Scholar